Atossa Therapeutics
ATOS
#9335
Rank
A$0.13 B
Marketcap
A$1.08
Share price
-1.90%
Change (1 day)
-32.77%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -A$46.92 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$38.24 Million, an increase over its 2023 earnings that were of -A$45.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$46.92 Million22.72%
2024 -A$38.24 Million-15.25%
2023 -A$45.12 Million11.62%
2022 -A$40.42 Million30.84%
2021 -A$30.89 Million15.58%
2020 -A$26.73 Million3.41%
2019 -A$25.85 Million51.16%
2018 -A$17.1 Million40.41%
2017 -A$12.18 Million27.54%
2016 -A$9.55 Million-47.49%
2015 -A$18.19 Million-17.25%
2014 -A$21.98 Million35.91%
2013 -A$16.17 Million112.3%
2012 -A$7.62 Million46.53%
2011 -A$5.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.56 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.99 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.92 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.76 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$62.48 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.17 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA